Genome Canada and the Canadian Institutes of Health Research (CIHR) today announced a $3.3 million investment in Can-SHARE – a pan-Canadian program that will enable innovation in the use of genomic data for health care for patients in Canada and worldwide. This program will create the policies and tools for Canadian clinicians and researchers to share genomic and clinical datasets across Canada and with international partners.
As the year draws to a close, we are delighted to mark Genome Canada’s 15-year anniversary. Since our inception in 2000, Genome Canada, in collaboration with six regional Genome Centres (Genome British Columbia, Genome Alberta, Genome Prairie, Ontario Genomics, Génome Québec and Genome Atlantic), proudly lead Canada’s genomics enterprise.
Genome Canada, in partnership with the Canadian Institutes of Health Research (CIHR), is seeking proposals for research projects to address any aspect of bioinformatics and computational biology (B/CB) as it relates to genomics. Proposals with applications across all of Genome Canada’s sectors are welcome. These include agriculture & agri-food, fisheries & aquaculture, forestry, energy, environment, human health and mining.
Canada now stands at the edge of an information and communications revolution of transformative social, economic and cultural impact.
The world’s increasing population, the corresponding growing demand for food, and climate variability will have profound impacts on the productive capacity of both oceans and agricultural lands. The knowledge of the genomic make-up, function and interaction of plants, livestock, fish and other species, has been rising, but its application to agricultural and aquatic productivity and food safety has been largely untapped until today.
Genome Canada (GC) and the Social Sciences and Humanities Research Council (SSHRC)have signed a joint initiative agreement to jointly support social sciences and humanities research and related activities pertaining to genomics, with one of the first initiatives focusing on societal implications of disruptive innovation in genomics.